Skip to main content
This section has no specific content
You will be redirected to the website of ROVI Spain in 5 seconds, where we will expand the information requested.
ACCESS
NO ACCESS
This section has no specific content
You will be redirected to the website of ROVI Spain in 5 seconds, where we will expand the information requested.
ACCESS
NO ACCESS
This section has no specific content
You will be redirected to the website of ROVI Spain in 5 seconds, where we will expand the information requested.
ACCESS
NO ACCESS
ROVI Subsidiaries
Spain
France
Italy
Germany
Poland
Portugal
United Kingdom
Ethics channel
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Enoxaparin Biosimilar
Contact
Products
Hospital Products
Diagnostic Products
OTC Products
Manufacturing
Contract manufacturing
Own product Manufacturing
R&D
Pipeline
ISM
Glycomics
Multilayer technologies
Shareholders and Investors
General information on the Company
How to contact the Company
Shares and share capital
Investor Agenda
Dividends
Public offerings and admission to trading
Public tender offers
Bylaws
Relevant events
Shareholders agreements
Significant interests and treasury shares
Analyst Coverage
Financial and economic information
Audit Report, Audited Annual Financial Statements (individual and consolidated), Management Report and Annual Report
Regular Public Information
Public information sent to regulatory bodies, other than information prepared under Spanish regulations
Rating
Average payment period to suppliers
Share Evolution
Stock Market History
Economic information
Share Value
Corporate Governance
Regulations of the Shareholders Meeting
General Shareholders' Meeting: exercising the right to information
Notice and Agenda of the Meeting
Shareholders request for information or clarification
Proxy voting
Distance voting at General Meetings
Information on the contents of past General Meetings
Board of Directors
Regulations of the Board of Directors
Annual Corporate Governance Report
Director compensation
Board Committees
Corporate Policies
Full texts of the proposed resolutions to be taken and the documentation available to the shareholder prior to the Meeting
Internal rules of conduct relating to trading in the securities market
Contact
Information for Investors
Annual Reports
Press Releases
Information for investors
Webcasts and other presentations
Contact
CSR
Mission, vision and values
Relations with Stakeholders
Commitment to Society
Commitment to the environment
Commitment to the employees
Media
FAQS
News
Contact
Work with Us
INTRANET
Home
Contact
News
News
Find out more …
FAQs
News
Contact
Filtrar resultados
Año
Year
-Year
2021
2022
2023
2024
2025
2026
2027
Desde
Date
E.g., 11/24/2024
Hasta
Date
E.g., 11/24/2024
24/02/2016
Full year 2015 results press release
181i.pdf
11/11/2015
Technologist joins our R&D&i program thanks to the EMPLEA program
180i.pdf
22/10/2015
Nine-month period ended 30 September 2015 press release
178i.pdf
22/10/2015
Nine-month period ended 30 September 2015 results presentation
179i.pdf
30/07/2015
First half 2015 results press release
176i.pdf
30/07/2015
First half 2015 results presentation
177i.pdf
30/06/2015
ROVI agrees to acquire assets of a manufacturing plant in San Sebastián de los Reyes
174i.pdf
26/06/2015
ROVI will present positive results of Risperidone ISM® and Bemiparin at the 12th EACPT Congress
175i.pdf
12/06/2015
ROVI announces the upcoming marketing of Orvatez in Spain
170i.pdf
29/04/2015
2015 first quarter results press release
166i.pdf
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »